Advertisement
Screener

ImmuCell Corporation (ICCC) Cash and Cash Equivalents, Period Increase (Decrease)

ImmuCell Corporation Cash and Cash Equivalents, Period Increase (Decrease)

ImmuCell Corporation (ICCC) reported Cash and Cash Equivalents, Period Increase (Decrease) of $1.61 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-13.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-13

  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was $1.61M, a 80.01% decline year-over-year.
  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $3.94M, a 2982.26% increase year-over-year.
  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $1.06M.
  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$9.29M.
  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for fiscal 2019 was $3.77M.
  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$1.28M.
  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$1.35M, a 137.78% decline from fiscal 2016.
  • ImmuCell Corporation cash and cash equivalents, period increase (decrease) for fiscal 2016 was $3.58M, a 394.54% increase from fiscal 2015.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2020-03-31$1.61M
10-Q · filed 2020-05-13
$5.55M
derived: sum of 2 quarters · filed 2020-05-13
$6.61M
derived: sum of 3 quarters · filed 2020-05-13
-$2.68M
derived: sum of 4 quarters · filed 2020-05-13
2019-12-31$3.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
$5.00M
derived: sum of 2 quarters · filed 2020-03-27
-$4.29M
derived: sum of 3 quarters · filed 2020-03-27
$3.77M
10-K · filed 2020-03-27
2019-09-30$1.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$8.23M
derived: sum of 2 quarters · filed 2019-11-12
-$166.49K
10-Q · filed 2019-11-12
-$38.70K
derived: sum of 4 quarters · filed 2020-05-13
2019-06-30-$9.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
-$1.23M
10-Q · filed 2019-08-12
-$1.10M
derived: sum of 3 quarters · filed 2020-05-13
-$1.22M
derived: sum of 4 quarters · filed 2020-05-13
2019-03-31$8.06M
10-Q · filed 2020-05-13
$8.19M
derived: sum of 2 quarters · filed 2020-05-13
$8.07M
derived: sum of 3 quarters · filed 2020-05-13
$7.52M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31$127.79K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
$6.53K
derived: sum of 2 quarters · filed 2020-03-27
-$539.42K
derived: sum of 3 quarters · filed 2020-03-27
-$1.28M
10-K · filed 2020-03-27
2018-09-30-$121.26K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$667.21K
derived: sum of 2 quarters · filed 2019-11-12
-$1.41M
10-Q · filed 2019-11-12
$88.00K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$545.95K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
-$1.28M
10-Q · filed 2019-08-12
$209.25K
derived: sum of 3 quarters · filed 2019-08-12
-$1.33M
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31-$738.34K
10-Q · filed 2019-05-13
$755.21K
derived: sum of 2 quarters · filed 2019-05-13
-$787.16K
derived: sum of 3 quarters · filed 2019-05-13
-$1.19M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
-$48.82K
derived: sum of 2 quarters · filed 2019-03-22
-$453.21K
derived: sum of 3 quarters · filed 2019-03-22
-$1.35M
10-K · filed 2019-03-22
2017-09-30-$1.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$1.95M
derived: sum of 2 quarters · filed 2018-11-13
-$2.85M
10-Q · filed 2018-11-13
-$2.10M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$404.39K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
-$1.30M
10-Q · filed 2018-08-13
-$560.78K
derived: sum of 3 quarters · filed 2018-08-13
$196.93K
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31-$898.32K
10-Q · filed 2018-05-14
-$156.40K
derived: sum of 2 quarters · filed 2018-05-14
$601.32K
derived: sum of 3 quarters · filed 2018-05-14
-$309.28K
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$741.93K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$1.50M
derived: sum of 2 quarters · filed 2018-03-29
$589.04K
derived: sum of 3 quarters · filed 2018-03-29
$3.58M
10-K · filed 2018-03-29
2016-09-30$757.72K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
-$152.89K
derived: sum of 2 quarters · filed 2017-11-13
$2.84M
10-Q · filed 2017-11-13
$1.94M
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30-$910.61K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$2.08M
10-Q · filed 2017-08-14
$1.18M
derived: sum of 3 quarters · filed 2017-08-14
$1.73M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$2.99M
10-Q · filed 2017-05-11
$2.09M
derived: sum of 2 quarters · filed 2017-05-11
$2.64M
derived: sum of 3 quarters · filed 2017-05-11
$2.09M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31-$895.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
-$351.85K
derived: sum of 2 quarters · filed 2017-03-30
-$896.76K
derived: sum of 3 quarters · filed 2017-03-30
$723.30K
10-K · filed 2017-03-30
2015-09-30$543.91K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
-$1.00K
derived: sum of 2 quarters · filed 2016-11-10
$1.62M
10-Q · filed 2016-11-10
$1.30M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30-$544.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$1.08M
10-Q · filed 2016-08-11
$758.97K
derived: sum of 3 quarters · filed 2016-08-11
$224.33K
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$1.62M
10-Q · filed 2016-05-11
$1.30M
derived: sum of 2 quarters · filed 2016-05-11
$769.24K
derived: sum of 3 quarters · filed 2016-05-11
$230.36K
derived: sum of 4 quarters · filed 2016-05-11
2014-12-31-$316.18K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
-$850.83K
derived: sum of 2 quarters · filed 2016-03-25
-$1.39M
derived: sum of 3 quarters · filed 2016-03-25
-$1.42M
10-K · filed 2016-03-25
2014-09-30-$534.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$1.07M
derived: sum of 2 quarters · filed 2015-11-12
-$1.10M
10-Q · filed 2015-11-12
-$1.77M
derived: sum of 4 quarters · filed 2016-03-25
2014-06-30-$538.88K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
-$569.53K
10-Q · filed 2015-08-13
-$1.23M
derived: sum of 3 quarters · filed 2016-03-25
-$739.37K
derived: sum of 4 quarters · filed 2016-03-25
2014-03-31-$30.65K
10-Q · filed 2015-05-12
-$695.63K
derived: sum of 2 quarters · filed 2016-03-25
-$200.50K
derived: sum of 3 quarters · filed 2016-03-25
-$80.71K
derived: sum of 4 quarters · filed 2016-03-25
2013-12-31-$664.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
-$169.84K
derived: sum of 2 quarters · filed 2016-03-25
-$50.05K
derived: sum of 3 quarters · filed 2016-03-25
-$403.33K
10-K · filed 2016-03-25
2013-09-30$495.13K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$614.92K
derived: sum of 2 quarters · filed 2014-11-12
$261.64K
10-Q · filed 2014-11-12
$1.35M
derived: sum of 4 quarters · filed 2015-03-26
2013-06-30$119.79K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13
-$233.49K
10-Q · filed 2014-08-13
$854.92K
derived: sum of 3 quarters · filed 2015-03-26
$1.41M
derived: sum of 4 quarters · filed 2015-03-26
2013-03-31-$353.28K
10-Q · filed 2014-05-14
$735.13K
derived: sum of 2 quarters · filed 2015-03-26
$1.29M
derived: sum of 3 quarters · filed 2015-03-26
$749.37K
derived: sum of 4 quarters · filed 2015-03-26
2012-12-31$1.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26
$1.64M
derived: sum of 2 quarters · filed 2015-03-26
$1.10M
derived: sum of 3 quarters · filed 2015-03-26
$1.89M
10-K · filed 2015-03-26
2012-09-30$551.54K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
$14.24K
derived: sum of 2 quarters · filed 2013-11-13
$803.79K
10-Q · filed 2013-11-13
$1.02M
derived: sum of 4 quarters · filed 2014-03-26
2012-06-30-$537.30K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13
$252.25K
10-Q · filed 2013-08-13
$470.22K
derived: sum of 3 quarters · filed 2014-03-26
$142.52K
derived: sum of 4 quarters · filed 2014-03-26
2012-03-31$789.55K
10-Q · filed 2013-05-14
$1.01M
derived: sum of 2 quarters · filed 2014-03-26
$679.82K
derived: sum of 3 quarters · filed 2014-03-26
$683.64K
derived: sum of 4 quarters · filed 2014-03-26
2011-12-31$217.97K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
-$109.73K
derived: sum of 2 quarters · filed 2014-03-26
-$105.91K
derived: sum of 3 quarters · filed 2014-03-26
-$617.47K
10-K · filed 2014-03-26
2011-09-30-$327.70K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13
-$323.88K
derived: sum of 2 quarters · filed 2012-11-13
-$835.44K
10-Q · filed 2012-11-13
-$2.27M
derived: sum of 4 quarters · filed 2013-03-28
2011-06-30$3.82K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07
-$507.74K
10-Q/A · filed 2012-09-07
-$1.94M
derived: sum of 3 quarters · filed 2013-03-28
-$853.50K
derived: sum of 4 quarters · filed 2013-03-28
2011-03-31-$511.56K
10-Q · filed 2012-05-14
-$1.94M
derived: sum of 2 quarters · filed 2013-03-28
-$857.32K
derived: sum of 3 quarters · filed 2013-03-28
2010-12-31-$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
-$345.76K
derived: sum of 2 quarters · filed 2013-03-28
$423.50K
10-K · filed 2013-03-28
2010-09-30$1.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$1.85M
10-Q · filed 2011-11-14
2010-06-30$769.26K
10-Q · filed 2011-08-15
2009-12-31-$224.44K
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92